Neuronetics, Inc. (STIM)
USD 4.58
(2.69%)
USD 4.58
(2.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -30.55 Million USD | 12.98% |
| 2022 | -35.11 Million USD | -27.38% |
| 2021 | -27.56 Million USD | -23.56% |
| 2020 | -22.3 Million USD | 17.16% |
| 2019 | -26.93 Million USD | -35.78% |
| 2018 | -19.83 Million USD | -45.75% |
| 2017 | -13.6 Million USD | -45.74% |
| 2016 | -9.33 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -8.5 Million USD | -24.03% |
| 2024 Q1 | -6.85 Million USD | -54.94% |
| 2023 Q3 | -8.87 Million USD | -20.71% |
| 2023 FY | -30.55 Million USD | 12.98% |
| 2023 Q1 | -9.9 Million USD | -28.23% |
| 2023 Q2 | -7.34 Million USD | 25.82% |
| 2023 Q4 | -4.42 Million USD | 50.1% |
| 2022 Q3 | -7.45 Million USD | 23.91% |
| 2022 FY | -35.11 Million USD | -27.38% |
| 2022 Q1 | -10.13 Million USD | -46.71% |
| 2022 Q2 | -9.79 Million USD | 3.34% |
| 2022 Q4 | -7.72 Million USD | -3.65% |
| 2021 Q1 | -6.9 Million USD | -159.74% |
| 2021 Q4 | -6.9 Million USD | 3.82% |
| 2021 Q3 | -7.18 Million USD | -9.41% |
| 2021 Q2 | -6.56 Million USD | 4.99% |
| 2021 FY | -27.56 Million USD | -23.56% |
| 2020 Q4 | -2.66 Million USD | -9.74% |
| 2020 Q2 | -6.85 Million USD | 33.83% |
| 2020 Q3 | -2.42 Million USD | 64.66% |
| 2020 FY | -22.3 Million USD | 17.16% |
| 2020 Q1 | -10.36 Million USD | -49.39% |
| 2019 FY | -26.93 Million USD | -35.78% |
| 2019 Q4 | -6.93 Million USD | -9.66% |
| 2019 Q3 | -6.32 Million USD | 4.22% |
| 2019 Q2 | -6.6 Million USD | 6.36% |
| 2019 Q1 | -7.05 Million USD | -24.64% |
| 2018 Q4 | -5.66 Million USD | -30.68% |
| 2018 FY | -19.83 Million USD | -45.75% |
| 2018 Q3 | -4.33 Million USD | 17.27% |
| 2018 Q2 | -5.23 Million USD | -13.7% |
| 2018 Q1 | -4.6 Million USD | -8.79% |
| 2017 FY | -13.6 Million USD | -45.74% |
| 2017 Q1 | -3.98 Million USD | 0.0% |
| 2017 Q4 | -4.23 Million USD | -50.64% |
| 2017 Q3 | -2.81 Million USD | -9.04% |
| 2017 Q2 | -2.57 Million USD | 35.38% |
| 2016 FY | -9.33 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -97.35 Million USD | 68.617% |
| Biodesix, Inc. | -41.34 Million USD | 26.095% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -283.207% |
| Castle Biosciences, Inc. | -67.97 Million USD | 55.052% |
| DarioHealth Corp. | -56.18 Million USD | 45.623% |
| Exact Sciences Corporation | -215.01 Million USD | 85.79% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 102.785% |
| Illumina, Inc. | -1.06 Billion USD | 97.142% |
| Intelligent Bio Solutions Inc. | -10.28 Million USD | -197.126% |
| iSpecimen Inc. | -11.16 Million USD | -173.552% |
| Standard BioTools Inc. | -76.6 Million USD | 60.112% |
| 23andMe Holding Co. | -321.35 Million USD | 90.492% |
| Medpace Holdings, Inc. | 336.82 Million USD | 109.071% |
| NeoGenomics, Inc. | -107.73 Million USD | 71.64% |
| Inotiv, Inc. | -81.46 Million USD | 62.492% |
| Psychemedics Corporation | -2.92 Million USD | -946.012% |
| Prenetics Global Limited | -52.51 Million USD | 41.817% |
| Precipio, Inc. | -7.62 Million USD | -300.971% |
| RadNet, Inc. | 98.69 Million USD | 130.957% |
| Sotera Health Company | 276.69 Million USD | 111.043% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -603.037% |
| Exagen Inc. | -22.83 Million USD | -33.792% |
| Natera, Inc. | -446.24 Million USD | 93.153% |
| Aspira Women's Health Inc. | -18.85 Million USD | -62.073% |
| Neogen Corporation | 58.66 Million USD | 152.084% |
| Myriad Genetics, Inc. | -123.7 Million USD | 75.3% |
| ICON Public Limited Company | 956.15 Million USD | 103.196% |
| Bionano Genomics, Inc. | -215.24 Million USD | 85.805% |
| CareDx, Inc | -101.9 Million USD | 70.016% |
| Check-Cap Ltd. | -19.28 Million USD | -58.418% |
| Twist Bioscience Corporation | -220.83 Million USD | 86.164% |
| Guardant Health, Inc. | -564.72 Million USD | 94.59% |
| BioNexus Gene Lab Corp. | -2.59 Million USD | -1078.059% |
| Fulgent Genetics, Inc. | -72.69 Million USD | 57.97% |
| Sera Prognostics, Inc. | -39.82 Million USD | 23.272% |
| OPKO Health, Inc. | -157.02 Million USD | 80.541% |
| Personalis, Inc. | -109.93 Million USD | 72.207% |
| Applied DNA Sciences, Inc. | -10.95 Million USD | -178.948% |
| Star Equity Holdings, Inc. | -4.34 Million USD | -603.037% |
| MDxHealth SA | -27.32 Million USD | -11.809% |
| Prenetics Global Limited | -52.51 Million USD | 41.817% |
| ENDRA Life Sciences Inc. | -10.52 Million USD | -190.417% |
| Mainz Biomed B.V. | -26.64 Million USD | -14.672% |
| Trinity Biotech plc | -27.04 Million USD | -12.975% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | -283.207% |